InsiderSignalSign in
← Insider buys

Michael Vincent Meluzio has sold CUE and made no open-market buys since Aug 2026

VP, Prin. Accounting Officer at Cue Biopharma, Inc.

SEC CIK 0002138368 · Filings on SEC.gov ↗

$0Bought
$201KSold
NoneLast buy

Every filing

2 filings since Aug 2026, newest first

CUESell

Cue Biopharma, Inc.

VP, Prin. Accounting Officer

$32K−2.3%Oct 14
CUESell

Cue Biopharma, Inc.

VP, Prin. Accounting Officer

$169K−10.3%Aug 17

Filings come from SEC EDGAR. Not investment advice.